{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "Etoglucid",
  "nciThesaurus": {
    "casRegistry": "1954-28-5",
    "chebiId": "",
    "chemicalFormula": "C12H22O6",
    "definition": "An epoxide compound with potential antineoplastic alkylating activity. Etoglucid is able to crosslink DNA via its epoxide group, resulting in disruption of DNA function and cell cycle arrest.",
    "fdaUniiCode": "4F9KUA0T4D",
    "identifier": "C489",
    "preferredName": "Etoglucid",
    "semanticType": "Organic Chemical",
    "subclassOf": [
      "C1590"
    ],
    "synonyms": [
      "1,2-Bis[2-(2, 3-epoxypropoxy)ethoxy]ethane",
      "1,2-bis[2-(2,3-epoxypropoxy)ethoxy]ethane",
      "1,2:15,16-Diepoxy-4,7,10, 13-tetraoxahexadecane",
      "1,2:15,16-diepoxy-4,7,10,13-tetraoxahexadecane",
      "2,2'-(2,5,8,11-tetraoxadodecane-1,12-diyl)bisoxirane",
      "ETOGLUCID",
      "Epodyl",
      "Ethane, 1, 2-bis[2-(2,3-epoxypropoxy)ethoxy]-",
      "Ethoglucid",
      "Etoglucid",
      "ICI 32865",
      "ICI-32865",
      "Triethylene Glycol Diglycidyl Ether",
      "Triethylene glycol diglycidyl ether"
    ]
  }
}